Your browser doesn't support javascript.
loading
Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study.
Han, Zhi-Yu; Dou, Jian-Pin; Zheng, Lin; Che, Ying; Yu, Ming-An; Wang, Shu-Rong; Wang, Hui; Cong, Zhi-Bin; He, Jun-Feng; Qian, Tong-Gang; Hu, Qiao-Hong; He, Guang-Zhi; Liu, Geng; Yu, Song-Yuan; Guo, Jian-Qin; Jiang, Tian-An; Feng, Rui-Fa; Li, Qin-Ying; Chen, Xiao-Jun; Zhu, Ya-Lin; Wei, Ying; Liu, Li-Hong; Wang, Xue; Qi, Li-Na; Liang, Ping.
Affiliation
  • Han ZY; Department of Interventional Ultrasound, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, China.
  • Dou JP; Department of Interventional Ultrasound, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, China.
  • Zheng L; Department of Interventional Ultrasound, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, China.
  • Che Y; Department of Ultrasound, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Yu MA; Department of Interventional Ultrasound Medicine, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Beijing, Chaoyang District, China.
  • Wang SR; Department of Medical Ultrasound, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
  • Wang H; Department of Ultrasound, China-Japan Union Hospital of Jilin University, No. 126, Xian Tai Street, Changchun, China.
  • Cong ZB; Department of Electrodiagnosis, the Affiliated Hospital to Changchun University of Traditional Chinese Medicine, Changchun, China.
  • He JF; Department of Ultrasound, the First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology, 41 Linyin Road, Kunqu District, Baotou City, Inner Mongolia Autonomous Region, China.
  • Qian TG; Department of Ultrasound, Zunhua People's Hospital, Hebei Province, Huaming Road, Zunhua, Hebei Province, China.
  • Hu QH; Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital, 158 Shangtang Road, Xiacheng District, Hangzhou City, Zhejiang, China.
  • He GZ; Department of Ultrasound, Shenzhen Hospital of University of Chinese Academy of Sciences, Shenzhen, China.
  • Liu G; Department of Ultrasound, Wuhai People's Hospital, No. 29, Huanghe East Street, Haibowan District, Wuhai City, Inner Mongolia Autonomous Region, China.
  • Yu SY; Department of Medical Ultrasound, the First Center of Minimally Invasive Treatment for, TumorShanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Guo JQ; Department of Interventional Ultrasound, Qinghai Provincial People's Hospital, Gonghe Road, Chengdong District, Xining City, Qinghai Province, China.
  • Jiang TA; Department of Ultrasound Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Zhejiang, Hangzhou, China.
  • Feng RF; Department of Ultrasound, breast and thyroid surgery, the Second Affiliated Hospital of Guilin Medical University, No.212, Renmin Road, Lingui District, Guilin City, Guangxi Province, China.
  • Li QY; Department of Interventional Ultrasound, Puyang Traditional Chinese medicine hospital, No.135 Shengli Road, Hualong District, Puyang City, Henan, China.
  • Chen XJ; Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou City, Zhejiang Province, China.
  • Zhu YL; Department of Ultrasound, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Wei Y; Department of Interventional Ultrasound Medicine, China-Japan Friendship Hospital, No. 2 Yinghuayuan East Street, Beijing, Chaoyang District, China.
  • Liu LH; Department of Medical Ultrasound, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
  • Wang X; Department of Electrodiagnosis, the Affiliated Hospital to Changchun University of Traditional Chinese Medicine, Changchun, China.
  • Qi LN; Department of Interventional Ultrasound, Qinghai Provincial People's Hospital, Gonghe Road, Chengdong District, Xining City, Qinghai Province, China.
  • Liang P; Department of Interventional Ultrasound, Chinese PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, China. liangping301@hotmail.com.
Eur Radiol ; 33(11): 7942-7951, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37294329
ABSTRACT

OBJECTIVES:

To assess the safety and efficacy of ultrasound-guided thermal ablation for low-risk papillary thyroid microcarcinoma (PTMC) via a prospective multicenter study.

METHODS:

From January 2017 through June 2021, low-risk PTMC patients were screened. The management details of active surveillance (AS), surgery, and thermal ablation were discussed. Among patients who accepted thermal ablation, microwave ablation (MWA) was performed. The main outcome was disease-free survival (DFS). The secondary outcomes were tumor size and volume changes, local tumor progression (LTP), lymph node metastasis (LNM), and complication rate.

RESULTS:

A total of 1278 patients were included in the study. The operation time of ablation was 30.21 ± 5.14 min with local anesthesia. The mean follow-up time was 34.57 ± 28.98 months. Six patients exhibited LTP at 36 months, of whom 5 patients underwent a second ablation, and 1 patient received surgery. The central LNM rate was 0.39% at 6 months, 0.63% at 12 months, and 0.78% at 36 months. Of the 10 patients with central LNM at 36 months, 5 patients chose ablation, 3 patients chose surgery and the other 2 patients chose AS. The overall complication rate was 1.41%, and 1.10% of patients developed hoarseness of the voice. All of the patients recovered within 6 months.

CONCLUSIONS:

Thermal ablation of low-risk PTMC was observed to be safe and efficacious with few minor complications. This technique may help to bridge the gap between surgery and AS as treatment options for patients wishing to have their PTMC managed in a minimally invasive manner. CLINICAL RELEVANCE STATEMENT This study proved that microwave ablation is a safe and effective treatment method for papillary thyroid microcarcinoma. KEY POINTS Percutaneous US-guided microwave ablation of papillary thyroid microcarcinoma is a very minimally invasive treatment under local anesthesia during a short time period. The local tumor progression and complication rate of microwave ablation in the treatment of papillary thyroid microcarcinoma are very low.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Radiofrequency Ablation Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Radiol Journal subject: RADIOLOGIA Year: 2023 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Radiofrequency Ablation Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Radiol Journal subject: RADIOLOGIA Year: 2023 Type: Article Affiliation country: China